Skip to main content

Clinolipid and Alcohol/Food Interactions

There are 2 alcohol/food/lifestyle interactions with Clinolipid (fat emulsion).

Major

Fat Emulsion, Intravenous High Cholesterol (Hyperlipoproteinemia, Hypertriglyceridemia, Sitosterolemia)

Major Potential Hazard, Moderate plausibility

fat emulsion - hypertriglyceridemia

Parenteral nutrition fat emulsion products are contraindicated in patients with severe lipid metabolism disorders characterized by hypertriglyceridemia (serum triglycerides greater than 1000 mg/dL). Patients with conditions such as inherited lipid disorders, diabetes mellitus, obesity, or metabolic syndromes are at increased risk while in treatment and should be monitored closely.

References

  1. (2023) "Product Information. Smoflipid (fat emulsion, intravenous)." Fresenius Kabi USA, LLC, SUPPL-10
Major

Fat Emulsion, Intravenous Obesity

Major Potential Hazard, Moderate plausibility

fat emulsion - hypertriglyceridemia

Parenteral nutrition fat emulsion products are contraindicated in patients with severe lipid metabolism disorders characterized by hypertriglyceridemia (serum triglycerides greater than 1000 mg/dL). Patients with conditions such as inherited lipid disorders, diabetes mellitus, obesity, or metabolic syndromes are at increased risk while in treatment and should be monitored closely.

References

  1. (2023) "Product Information. Smoflipid (fat emulsion, intravenous)." Fresenius Kabi USA, LLC, SUPPL-10

Clinolipid drug interactions

There is 1 drug interaction with Clinolipid (fat emulsion).

Clinolipid disease interactions

There are 2 disease interactions with Clinolipid (fat emulsion) which include:

Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer